AlphaTON Capital Corp Announces Intention to Launch Decentralized AI-Native Biotech Platform Focused on Rare Cancers

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (NASDAQ: ATON), the world's leading public technology company scaling the Telegram super app, with an addressable market of 1 billion monthly active users, today announced its intention to launch a decentralized, AI-native biotech platform focused on rare and immune-suppressed cancers, starting with mesothelioma.